Top compounds associated with response to SETD4


Feature Type Standardized
Nominal ANOVA
mRNA lenalidomide FIMM pan-cancer AAC -0.47 0.002
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.003
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC 0.085 0.004
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.004
mRNA necrostatin-1 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA LY317615 GDSC1000 pan-cancer AAC 0.097 0.004
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.005
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.079 0.007
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.097 0.007
Download CSV